RichardAmesLeigh-PembertonMD

Internal Medicine • Boston, MA

Physician

Join to view full profile

Dr. Leigh-Pemberton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leigh-Pemberton's full profile

Already have an account?

Office
222 Beacon St
# 24
Boston, MA 02116
Phone+1 617-247-6449

Education & Training

Tufts Medical CenterResidency, Internal Medicine, 2000 - 2003
Columbia University Vagelos College of Physicians and SurgeonsClass of 2000

Certifications & Licensure

MA State Medical License 2003 - 2024

Clinical Trials

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD) Start of enrollment: 2011 Dec 01
Completed
Phase 2
A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults Start of enrollment: 2014 Jul 01
Completed
Phase 1
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 Start of enrollment: 2015 Dec 10
Completed
Phase 3
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2 Start of enrollment: 2017 Mar 15
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers.
Francis M Dijkstra, Rob G J A Zuiker, Pieter S Siebenga, Richard A Leigh-Pemberton, Lei Sun
British Journal of Clinical Pharmacology. 2022-06-01
76 citations
Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Scleros...
Robert T. Naismith, Annette Wundes, Tjalf Ziemssen, Elzbieta Jasinska, Mark S. Freedman
CNS Drugs. 2020-02-01
40 citations
Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitt...
Michael J. Palte, Angela Wehr, Mark Tawa, Kristopher Perkin, Richard Leigh-Pemberton
Advances in Therapy. 2019-09-19